HOME

Manufacturer: Pfizer

Selzentry is available in 150 and 300 mg tablets, and must be taken twice a day. There is no “standard” dose for Selzentry. The dosing varies depending on which other medications you take with it.

Evaluation: Selzentry is a new drug, approved by the FDA in August, 2007. It was originally approved only for experienced patients who are resistant to multiple HIV drugs. But the FDA recently expanded its approval to include treatment-naive patients also.

Selzentry is the first in a new class of drugs called “entry inhibitors.” It stops HIV from entering your cells using the CCR5 receptor. Unfortunately, it does not work against strains of the virus that use another receptor, called CXCR4. You should have a “tropism assay” done before taking Selzentry to see if the drug will work for you.

Copyright 2010, Positive Health Publications, Inc.

This magazine is intended to enhance your relationship with your doctor - not replace it! Medical treatments and products should always be discussed with a licensed physician who has experience treating HIV and AIDS!